Curaleaf Holdings, Inc. Form 8-K Filing

Curaleaf Holdings, Inc. has filed a Form 8-K report detailing a significant event on September 16, 2026. The company has published a brochure for Aurora's shareholders, encouraging them to tender their shares to Curaleaf's offer. This offer presents Aurora's shareholders with a 45% premium, implying a value of US$4.00 per Aurora share, and an opportunity to become owners of the combined entity. Curaleaf highlights the strategic advantages of this acquisition, including the creation of the world's leading global cannabis company with operations in 17 countries, over US$1.5 billion in trailing twelve months (LTM) revenue, nearly US$350 million in adjusted EBITDA, and expected annual cost synergies of at least US$40 million. The brochure contrasts this offer with Aurora's recent performance, citing declining revenues and adjusted EBITDA, negative operating cash flow, and a history of dilutive equity issuances. Curaleaf emphasizes that the combined company would offer broader growth opportunities, greater scale, and improved access to capital, positioning it as a stronger platform compared to Aurora's standalone path.